MaxCyte, Inc. Presents Scalable Flow Electroporation as a Universal Platform for High Titer Antibody and Protein Production at CHI’s PEGS Europe Summit
11/4/2013 8:06:37 AM
MaxCyte, Inc., the pioneer in scalable, high performance cell transfection systems, is holding a series of events at Cambridge Health Institute’s Fifth Annual PEGS Europe Protein & Antibody Engineering Summit to be held November 4-8, 2013, at the Sheraton Hotel & Spa in Lisbon, Portugal. MaxCyte will present data in both podium and poster presentations emphasizing the universality of MaxCyte flow electroporation for the rapid, high titer production of antibodies and other proteins such as bi-specific antibodies, recombinant proteins, VLPs, and viral vectors
Help employers find you! Check out all the jobs and post your resume.
comments powered by